Assuntos
Ácidos Araquidônicos/uso terapêutico , Di-Hidroxiacetona/uso terapêutico , Fígado Gorduroso Alcoólico/prevenção & controle , Piruvatos/uso terapêutico , Riboflavina/uso terapêutico , Trioses/uso terapêutico , Animais , Gorduras na Dieta/administração & dosagem , Etanol , Fígado Gorduroso/induzido quimicamente , Fígado Gorduroso Alcoólico/metabolismo , Metabolismo dos Lipídeos , Mobilização Lipídica/efeitos dos fármacos , Masculino , RatosRESUMO
The authors' previous studies have shown that hepatic steatosis of chronic ethanol ingestion in rats can be prevented by adding pyruvate, dihydroxyacetone, and riboflavin to their diet. In this study, the authors investigated the effect of chronic ethanol ingestion, with or without addition of the above metabolites to the diet, on protein and amino acid concentrations in tissues. Rats (120 g) were divided into three groups and fed isocalorically one of the fellowing diets for 30 days: control diet (28% fat, 15% protein, and 57% carbohydrate), ethanol diet (28% fat, 15% protein, 23% carbohydrate, and 24% ethanol), and metabolite diet (ethanol diet plus pyruvate, dihydroxyacetone, and riboflavin). Chronic ethanol ingestion reduced growth of muscle and intestinal mucosa without affecting that of liver and kidney. Among the 15 amino acids measured, chronic ethanol ingestion had the most consistent effect on plasma and tissue concentrations of leucine, alanine and alpha-amino-n-butyrate. The concentration of leucine was increased in muscle, liver, and plasma; that of alpha-amino-n-butyrate was increased in muscle and plasma, whereas that of alanine was decreased in plasma and liver. Addition of pyruvate, dihydroxyacetone, and riboflavin to the ethanol diet either totally or partially prevented ethanol-induced changes in plasma and tissue concentrations of amino acids despite similarity in plasma ethanol levels. Although these metabolites prevented the inhibition of the growth of intestinal mucosa, they were ineffective in blunting the effect of ehtanol on the skeletal muscle. This latter observation suggests that the mechanism of ethanol-induced inhibition of tissue growth is not the same for these tissues.
Assuntos
Aminoácidos/metabolismo , Di-Hidroxiacetona/uso terapêutico , Fígado Gorduroso Alcoólico/prevenção & controle , Fígado/metabolismo , Músculos/metabolismo , Proteínas/metabolismo , Piruvatos/uso terapêutico , Riboflavina/uso terapêutico , Trioses/uso terapêutico , Aminoácidos/sangue , Fenômenos Fisiológicos da Nutrição Animal , Animais , Di-Hidroxiacetona/administração & dosagem , Etanol/administração & dosagem , Fígado/efeitos dos fármacos , Masculino , Músculos/efeitos dos fármacos , Piruvatos/administração & dosagem , Ratos , Riboflavina/administração & dosagemRESUMO
30 patients with multiple types of sunlight sensitivity were treated successfully with DHA/lawsone sunscreen. This sunscreen was able to protect all patients even though their photosensitivities were in different parts of the ultraviolet and visible spectrum. About 80% of the patients experienced sufficient protection during the summer months to lead a virtually normal life-style while participating in all kinds of outdoor activities.
Assuntos
Di-Hidroxiacetona/uso terapêutico , Naftoquinonas/uso terapêutico , Transtornos de Fotossensibilidade/tratamento farmacológico , Protetores Solares/uso terapêutico , Trioses/uso terapêutico , Administração Tópica , Ensaios Clínicos como Assunto , Di-Hidroxiacetona/administração & dosagem , Combinação de Medicamentos , Avaliação de Medicamentos , Humanos , Naftoquinonas/administração & dosagemRESUMO
Dihydroxyacetone (DHA) chemically induces long ultraviolet (UV) and/or visible photoprotection into the stratum corneum as demonstrated by (a) long UV protection of albino rats which were psoralen-photosensitized to black fluorescent light and (b) sunlight protection of five patients with long UV and/or visible photosensitivity. Previously, DHA treatment of skin was considered to provide no protection against UV. For clinical use, the combination of DHA and lawsone (2-hydroxy-1,4-naphthoquinone) is preferred to DHA alone, because it provides rapid, positive protection over a range extending from short UV into the visible region of sunlight.